PERSPECTIVE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $71.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-03-16
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-12-31 was $608.99M.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-09-30 was $37.00K, a 3600.00% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-06-30 was $570.00K.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $71.19M, a 96.43% decline from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.99B, a 227.22% increase from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $609.60M.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $3.00K, a 99.61% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $71.19M 10-K · filed 2026-03-16 | ||||||
| 2024-12-31 | $1.99B 10-K · filed 2026-03-16 | ||||||
| 2023-12-31 | $608.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-03-28 | $609.03M derived: sum of 2 quarters · filed 2025-03-28 | $609.60M derived: sum of 3 quarters · filed 2025-03-28 | $609.60M 10-K/A · filed 2025-03-28 | $610.00K 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $37.00K 10-Q · filed 2023-11-14 | $607.00K derived: sum of 2 quarters · filed 2023-11-14 | $607.00K 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $570.00K 10-Q · filed 2023-08-11 | $570.00K 10-Q · filed 2023-08-11 | |||||
| 2022-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | $1.00K 10-K · filed 2024-03-28 | $1.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.00K derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-14 | $1.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.00K 10-Q · filed 2023-11-14 | $4.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $3.00K derived: sum of 3 quarters · filed 2023-08-11 | $3.00K 10-K · filed 2024-03-28 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $3.00K derived: sum of 2 quarters · filed 2022-05-13 | $3.00K 10-Q · filed 2022-05-13 | $120.00K derived: sum of 4 quarters · filed 2023-05-01 | |||
| 2021-12-31 | $3.00K 10-Q · filed 2022-02-09 | $3.00K 10-Q · filed 2022-02-09 | $120.00K derived: sum of 3 quarters · filed 2023-05-01 | $772.00K derived: sum of 4 quarters · filed 2023-05-01 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $117.00K derived: sum of 2 quarters · filed 2023-05-01 | $769.00K derived: sum of 3 quarters · filed 2023-05-01 | $770.00K derived: sum of 4 quarters · filed 2023-05-01 | |||
| 2021-06-30 | $117.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | $769.00K derived: sum of 2 quarters · filed 2023-05-01 | $770.00K derived: sum of 3 quarters · filed 2023-05-01 | $770.00K 10-KT · filed 2023-05-01 | |||
| 2021-03-31 | $652.00K 10-Q · filed 2022-05-13 | $653.00K derived: sum of 2 quarters · filed 2022-05-13 | $653.00K 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $1.00K 10-Q · filed 2022-02-09 | $1.00K 10-Q · filed 2022-02-09 | |||||
| 2020-06-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | $83.00K derived: sum of 2 quarters · filed 2023-05-01 | $83.00K 10-KT · filed 2023-05-01 | ||||
| 2020-03-31 | $83.00K 10-Q · filed 2021-05-14 | $83.00K 10-Q · filed 2021-05-14 | |||||
| 2019-06-30 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | $11.00K derived: sum of 2 quarters · filed 2021-09-27 | $11.00K derived: sum of 3 quarters · filed 2021-09-27 | $11.00K 10-K · filed 2021-09-27 | |||
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-13 | $1.00K derived: sum of 2 quarters · filed 2020-05-13 | $1.00K 10-Q · filed 2020-05-13 | ||||
| 2018-12-31 | $0.00 10-Q · filed 2019-02-13 | $0.00 10-Q · filed 2019-02-13 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-05-10 | $0.00 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $0.00 10-Q · filed 2019-02-13 | $0.00 10-Q · filed 2019-02-13 | |||||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $0.00 derived: sum of 2 quarters · filed 2019-09-27 | $3.00K derived: sum of 3 quarters · filed 2019-09-27 | $3.00K 10-K · filed 2019-09-27 | |||
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-04 | $3.00K derived: sum of 2 quarters · filed 2018-05-04 | $3.00K 10-Q · filed 2018-05-04 | $4.00K derived: sum of 4 quarters · filed 2018-09-26 | |||
| 2016-12-31 | $3.00K 10-Q · filed 2018-02-09 | $3.00K 10-Q · filed 2018-02-09 | $4.00K derived: sum of 3 quarters · filed 2018-09-26 | $9.00K derived: sum of 4 quarters · filed 2018-09-26 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | $1.00K derived: sum of 2 quarters · filed 2018-09-26 | $6.00K derived: sum of 3 quarters · filed 2018-09-26 | $6.35K derived: sum of 4 quarters · filed 2018-09-26 | |||
| 2016-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | $6.00K derived: sum of 2 quarters · filed 2018-09-26 | $6.35K derived: sum of 3 quarters · filed 2018-09-26 | $28.00K 10-K · filed 2018-09-26 | $24.59K 10-K · filed 2016-09-09 | ||
| 2016-03-31 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $5.35K derived: sum of 2 quarters · filed 2017-05-10 | $27.00K 10-Q · filed 2017-05-10 | $27.47K 10-Q · filed 2016-05-10 | $188.72K derived: sum of 4 quarters · filed 2017-09-28 | ||
| 2015-12-31 | $346.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $22.00K 10-Q · filed 2017-02-09 | $21.65K 10-Q · filed 2016-02-09 | $183.72K derived: sum of 3 quarters · filed 2017-09-28 | $76.69K derived: sum of 4 quarters · filed 2017-09-28 | ||
| 2015-09-30 | $21.65K 10-Q · filed 2016-11-09 | $183.38K derived: sum of 2 quarters · filed 2017-09-28 | $76.35K derived: sum of 3 quarters · filed 2017-09-28 | $76.35K derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-06-30 | $161.72K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $54.69K derived: sum of 2 quarters · filed 2017-09-28 | $54.69K derived: sum of 3 quarters · filed 2017-09-28 | $307.00K 10-K · filed 2017-09-28 | $306.62K 10-K · filed 2015-09-14 | ||
| 2015-03-31 | -$107.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | -$107.03K derived: sum of 2 quarters · filed 2016-05-10 | $145.28K 10-Q · filed 2016-05-10 | $679.07K derived: sum of 4 quarters · filed 2016-09-09 | |||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $252.31K 10-Q · filed 2016-02-09 | $786.11K derived: sum of 3 quarters · filed 2016-09-09 | ||||
| 2014-09-30 | $252.31K 10-Q · filed 2015-11-09 | $786.11K derived: sum of 2 quarters · filed 2016-09-09 | |||||
| 2014-06-30 | $533.80K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | $548.93K 10-K · filed 2016-09-09 | |||||
| 2014-03-31 | $15.13K 10-Q · filed 2015-05-15 | ||||||
| 2013-06-30 | $2.38K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $2.38K derived: sum of 2 quarters · filed 2015-09-14 | $4.85K derived: sum of 3 quarters · filed 2015-09-14 | $16.25K 10-K · filed 2015-09-14 | |||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | $2.47K derived: sum of 2 quarters · filed 2014-05-15 | $13.87K 10-Q · filed 2014-05-15 | $24.67K derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2012-12-31 | $2.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $13.87K 10-Q · filed 2014-02-14 | $24.67K derived: sum of 3 quarters · filed 2014-02-14 | $24.67K derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-09-30 | $11.40K 10-Q · filed 2013-11-14 | $22.20K derived: sum of 2 quarters · filed 2013-11-14 | $22.20K derived: sum of 3 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $10.80K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | $10.80K derived: sum of 2 quarters · filed 2013-09-30 | $13.76K 10-K · filed 2013-09-30 | ||||
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $2.96K 10-Q · filed 2013-05-15 | |||||
| 2011-12-31 | $2.96K 10-Q · filed 2013-02-14 | ||||||
| 2011-06-30 | $15.60K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |